BIOLIFE SOLUTIONS INC

BLFS

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0001628280-26-015342
Filing date: Mar 5, 2026
Earliest execution date: Mar 3, 2026
Reporting Owners: Werner Sean (Chief Technology Officer)
SEC Filing link

Summary

Type

Sell

Net shares

-111

% of shares

-0.22%

Amount (USD)

$2,302

Insider confidence score

53.8 out of 100

Positive

  • Under Rule 10b5-1 trading plan
  • Tiny scheduled sell (<0.25% of shares)
  • Minimal sell amount (<$10K)

Stock transactions

Transaction 1

Security

Common Stock

Action

Sell

Date

2026-03-03

Code

S

Net shares

-111.0

Price per Share

$20.74

Amount (USD)

$2,302.14

Acquired/Disposed

Disposed

Shares Owned Before

50,043.0

Shares Owned After

49,932.0

Filing's footnotes

1. The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

ℹ️ Filed under Rule 10b5-1 trading plan

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.